Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy

J Gastroenterol Hepatol. 2016 May;31(5):910. doi: 10.1111/jgh.13239.

Authors

Ian Gassiep^{1

2}, Paul J Clark^{3

2

4}, Don P McManus⁴, David L Looke^{1

2}

Affiliations

¹ Department of Infectious Diseases, Princess Alexandra Hospital, Queensland Health, Australia.
² School of Medicine, University of Queensland, Brisbane, QLD, Australia.
³ Department of Gastroenterology, Princess Alexandra Hospital, Queensland Health, Brisbane, Australia.
⁴ QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

PMID: 26598933
DOI: 10.1111/jgh.13239

No abstract available

Publication types

Case Reports

MeSH terms

Acute Disease
Animals
Anthelmintics / adverse effects
Anthelmintics / therapeutic use*
Anti-Inflammatory Agents / therapeutic use
Biopsy
Chronic Disease
Hepatitis / diagnosis
Hepatitis / drug therapy
Hepatitis / parasitology*
Humans
Liver Cirrhosis / diagnosis
Liver Cirrhosis / drug therapy
Liver Cirrhosis / parasitology*
Male
Praziquantel / adverse effects
Praziquantel / therapeutic use*
Prednisone / therapeutic use
Schistosoma mansoni / drug effects*
Schistosoma mansoni / isolation & purification
Schistosomiasis mansoni / complications
Schistosomiasis mansoni / diagnosis
Schistosomiasis mansoni / drug therapy*
Schistosomiasis mansoni / parasitology
Treatment Outcome
Young Adult

Substances

Anthelmintics
Anti-Inflammatory Agents
Praziquantel
Prednisone